GOLDMAN SACHS GROUP INC (GS) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | GS | PFE |
|---|---|---|
| Sector | Financials | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $58.28B | $62.58B |
| Revenue growth (YoY) | ▲ 8.9% | ▼ 1.6% |
| Net income | $17.18B | $7.81B |
| Gross margin | — | — |
| Diluted EPS | $51.32 | $1.36 |
| Insider net (6 mo) | +24.5M sh · 21 sells · 20 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 45 | 44 |
| Institutional value held | $163.75B | $61.93B |
| Next earnings (est.) | Oct 13, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About GOLDMAN SACHS GROUP INC (GS)
The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation, is a leading global financial institution providing a broad range of financial services to a diversified client base including corporations, financial institutions, governments, and individual
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.